DNA X, Inc. (SONM) stock
SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
$2.17−0.21 (-8.82%)
Close on Nov 13, 2026Market cap $3.23MP/E –Yield –
DNA X price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
DNA X's price to sales ratio was 0.1× on Jan 30, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.1× to 1.1×, with a median of 0.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 0.1× | +0.0 |
| 2025 | Dec 31, 2025 | 0.1× | −0.2 |
| 2024 | Dec 31, 2024 | 0.3× | −0.0 |
| 2023 | Dec 29, 2023 | 0.3× | +0.0 |
| 2022 | Dec 30, 2022 | 0.3× | +0.1 |
| 2021 | Dec 31, 2021 | 0.2× | −0.3 |
| 2020 | Dec 31, 2020 | 0.5× | −0.0 |
| 2019 | Dec 31, 2019 | 0.5× | – |
See a number that looks wrong?